Ken Griffin West Pharmaceutical Services Inc Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 727,537 shares of WST stock, worth $190 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
727,537
Previous 128,786
464.92%
Holding current value
$190 Million
Previous $28.2 Million
577.32%
% of portfolio
0.03%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding WST
# of Institutions
852Shares Held
68.1MCall Options Held
285KPut Options Held
106K-
Vanguard Group Inc Valley Forge, PA9.7MShares$2.54 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$1.98 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.21MShares$838 Million0.03% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.77MShares$724 Million1.11% of portfolio
-
Brown Advisory Inc2.5MShares$653 Million0.92% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $19.3B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...